statistiche ricercatore

MAGGI, FABRIZIO

Distribuzione geografica

Continente	#
NA - Nord America	15.178
AS - Asia	7.812
EU - Europa	5.725
SA - Sud America	2.206
AF - Africa	192
Continente sconosciuto - Info sul continente non disponibili	11
OC - Oceania	11
Totale	31.135

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	14.967
SG - Singapore	2.964
BR - Brasile	1.781
VN - Vietnam	1.690
IT - Italia	1.650
CN - Cina	1.231
HK - Hong Kong	1.214
IE - Irlanda	881
SE - Svezia	587
DE - Germania	582
FR - Francia	531
RU - Federazione Russa	392
UA - Ucraina	373
GB - Regno Unito	304
AR - Argentina	182
FI - Finlandia	169
IN - India	129
BD - Bangladesh	100
MX - Messico	100
ID - Indonesia	99
JP - Giappone	89
CA - Canada	69
EC - Ecuador	69
IQ - Iraq	58
ZA - Sudafrica	50
NL - Olanda	44
CO - Colombia	41
PL - Polonia	40
PY - Paraguay	40
ES - Italia	32
UZ - Uzbekistan	31
AT - Austria	30
NG - Nigeria	30
CL - Cile	28
PK - Pakistan	28
MA - Marocco	26
TR - Turchia	25
VE - Venezuela	24
BE - Belgio	22
PE - Perù	21
SA - Arabia Saudita	21
EG - Egitto	18
KE - Kenya	18
LT - Lituania	17
NP - Nepal	14
UY - Uruguay	14
PH - Filippine	13
AZ - Azerbaigian	12
CZ - Repubblica Ceca	12
DZ - Algeria	12
TN - Tunisia	11
JO - Giordania	10
DO - Repubblica Dominicana	9
KZ - Kazakistan	9
LB - Libano	9
AE - Emirati Arabi Uniti	8
AU - Australia	8
BG - Bulgaria	8
ET - Etiopia	8
IL - Israele	8
MY - Malesia	8
OM - Oman	8
EU - Europa	7
HR - Croazia	7
RO - Romania	7
BB - Barbados	6
CI - Costa d'Avorio	5
TH - Thailandia	5
AL - Albania	4
BO - Bolivia	4
HU - Ungheria	4
JM - Giamaica	4
NI - Nicaragua	4
PT - Portogallo	4
SK - Slovacchia (Repubblica Slovacca)	4
BN - Brunei Darussalam	3
BY - Bielorussia	3
EE - Estonia	3
GA - Gabon	3
GE - Georgia	3
GR - Grecia	3
GT - Guatemala	3
HN - Honduras	3
LK - Sri Lanka	3
MD - Moldavia	3
PA - Panama	3
QA - Qatar	3
TZ - Tanzania	3
XK - ???statistics.table.value.countryCode.XK???	3
AM - Armenia	2
BH - Bahrain	2
BW - Botswana	2
CH - Svizzera	2
CR - Costa Rica	2
CU - Cuba	2
CY - Cipro	2
DM - Dominica	2
GY - Guiana	2
IR - Iran	2
KW - Kuwait	2
Totale	31.107

Salva come PNG Salva come JPEG

Città	#
San Jose	1.783
Singapore	1.501
Ashburn	1.459
Fairfield	1.289
Hong Kong	1.205
Jacksonville	961
Milan	892
Dublin	864
Princeton	737
Dallas	695
Chandler	651
Wilmington	636
Woodbridge	490
The Dalles	467
Houston	445
Nyköping	438
Seattle	422
Boardman	409
Cambridge	381
Ho Chi Minh City	376
Lauterbourg	370
Dong Ket	334
Chicago	309
Beijing	304
Los Angeles	241
Council Bluffs	221
Hanoi	192
Redwood City	176
San Diego	175
New York	173
São Paulo	155
Ogden	142
Ann Arbor	138
Helsinki	128
Washington	126
Salt Lake City	113
Rome	108
London	105
Santa Clara	100
Tokyo	84
Como	70
Tampa	67
Elk Grove Village	58
Mexico City	58
Munich	58
Haiphong	57
Buffalo	56
Frankfurt am Main	56
Rio de Janeiro	52
Guangzhou	47
Lancaster	47
Norwalk	47
Da Nang	42
Orem	42
Brasília	40
Varese	38
Warsaw	35
Belo Horizonte	32
Chennai	30
Abuja	29
Biên Hòa	28
Porto Alegre	28
Shanghai	28
Shenzhen	28
Brooklyn	27
Denver	27
Nuremberg	27
Stockholm	26
Tashkent	26
Atlanta	25
Sterling	25
Dhaka	24
Hangzhou	24
Montreal	24
San Francisco	24
Baghdad	23
Curitiba	23
Guarulhos	23
Johannesburg	23
Ninh Bình	22
Poplar	22
Campinas	21
Turku	21
Brussels	19
Falkenstein	19
Phoenix	19
Quito	19
Salvador	19
Thái Bình	19
Buenos Aires	18
Can Tho	18
Guayaquil	18
Kilburn	18
Ribeirão Preto	18
Toronto	18
Boston	17
Hải Dương	17
Manchester	17
Moscow	17
Zhengzhou	17
Totale	21.632

Salva come PNG Salva come JPEG

Nome	#
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	463
Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients	266
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin	238
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	223
Viral hepatitis	208
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections	195
Torque Teno virus: any pathological role in liver transplanted patients?	194
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples	184
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9	179
Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2	178
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	165
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine	161
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	160
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates	160
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children	159
Immunobiology of the Torque teno viruses and other anelloviruses	157
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	156
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease	155
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection	155
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients	150
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease	145
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19	142
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients	137
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	135
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection	132
Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+NaiVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study	131
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol	129
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection	128
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients	127
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy	127
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy	126
Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus?	124
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs	122
HIV-1 NAT minipool during the pre-seroconversion window period: Detection of a repeat blood donor	122
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021	122
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis	121
Asymptomatic SARS-CoV-2 vaccine breakthrough infections in health care workers identified through routine universal surveillance testing	119
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022	117
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon?	117
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale	117
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study	116
Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects	115
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine	114
Anelloviruses and immune competence	114
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis	113
Zika Virus: Implications for Public Health	112
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: Old drugs for an old disease	110
TT virus in the nasal secretions of children with acute respiratory diseases: Relations to viremia and disease severity	109
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review	109
TTV and other anelloviruses: The astonishingly wide spread of a viral infection	108
Sialic acid moieties and 5-HT(2a): Two faces of the same receptor for JC virus?	107
Assessment of prevalence and load of torquetenovirus viremia in a large cohort of healthy blood donors	107
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy	107
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy	106
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022	105
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects	105
Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon alpha	105
A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans	105
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients	105
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus (TTV) viremia, the new surrogate marker of immune competence	104
Human anelloviruses and the central nervous system	104
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution	104
Immunosuppressive monoclonal antibodies: current and next generation	102
A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers	102
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study	102
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis	101
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases	101
Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia	99
Attempt to classify the clinical impact of DNA viruses according to the ability to activate the innate immune system	99
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy	99
Anellovirus	98
Getting the most from the Ebola vaccine success	98
In vitro sensitivity of human metapneumovirus to type i interferons	97
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody	97
Anellovirus	95
Anellovirus	95
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease	95
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability	95
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients	94
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients	93
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans	93
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies	93
5-HT2a antagonists as a new treatment for JCV-associated progressive multifocal leukoencephalopathy	92
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein	92
Expression of MxA mRNA in PBL from chronic hepatitis C patients and response to interferon-alpha therapy	91
TT virus infection of periodontal tissues: A controlled clinical and laboratory pilot study	91
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs	91
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients	90
Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia	90
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders	90
Cell therapies for treatment of human immunodeficiency virus infection	90
Role of Hematopoietic Cells in the Maintenance of Chronic Human Torquetenovirus Plasma Viremia	90
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients	89
Olfactory and gustatory impairments in COVID-19 patients: role in early diagnosis and interferences by concomitant drugs	89
Lack of Marseillevirus DNA in immunocompetent and immunocompromised Italian patients	88
Dynamics of persistent TT virus infection, as estimated in patients treated with alpha interferon for concomitant hepatitis C	88
Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried	88
Classification of hepatitis C virus type 2 isolates by phylogenetic analysis of core and NS5 regions	88
On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin	88
Anellovirus e virus simili	87
Totale	12.390

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	171.901
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	171.901

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.566	0	0	0	0	0	0	0	0	0	247	399	920
2021/2022	2.921	242	386	65	113	52	129	181	231	165	574	297	486
2022/2023	2.586	442	148	149	151	81	638	30	256	370	195	58	68
2023/2024	2.847	233	234	256	569	574	483	49	79	216	46	17	91
2024/2025	5.308	19	39	885	102	64	381	98	166	624	375	811	1.744
2025/2026	12.652	669	800	1.411	2.889	731	357	2.449	980	1.709	657	0	0
Totale													31.805